Clinical Trials maintenance - Pancreatic Cancer - Archives

Illustration of a protein that includes the BRCA2 mutation. The illustration includes spirals in brown, strands in purple, blue directional arrows, and green, yellow, red, and blue circles.

A Maintenance Trial for Patients with BRCA or PALB2 Mutations

A clinical trial examines whether the PARP inhibitor rucaparib can work as a maintenance drug for pancreatic cancer patients with BRCA or PALB2 mutations.

photo of yellow pills in silver bubble packets

Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer

A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.

Clear cylinders--test tubes--with somethiing tan-colored in each plus a liquid, against a blue background. Other lab glassware pieces are visible in the background.

Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation

A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.

Join our community Sign up for updates from Let’s Win!

Terms & Conditions • Privacy Policy

Let’s Win! Pancreatic Cancer is an online community for sharing information about innovative, science-based treatments for pancreatic cancer. Please note that this information is not intended to be a substitute for professional medical opinion, advice, or diagnosis. We encourage you to use this information to begin a dialogue with your physician about the treatment plan that is right for you.